{
  "id": 3669,
  "text": "Ann Oncol 12, 967-974 (2001).1668.Coronel, J., et al.A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Ann Oncol 12, 967-974 (2001).1668.Coronel, J., et al.A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于晚期宫颈癌患者的治疗方案，有研究在临床试验中采用了化疗联合表观遗传疗法，具体为使用氢氯噻唑和丙戊酸。这项研究设计为双盲、安慰剂对照、随机化的三期试验。该方案旨在评估这两种药物在化疗基础上的潜在益处，为晚期宫颈癌治疗提供新的思路。",
  "query": "对于患有晚期宫颈癌的患者，哪种治疗方案在临床试验中被研究为合并化疗和表观遗传疗法的一部分，并且采用了双盲、安慰剂对照、随机化的研究设计？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于患有晚期宫颈癌的患者，哪种治疗方案在临床试验中被研究为合并化疗和表观遗传疗法的一部分，并且采用了双盲、安慰剂对照、随机化的研究设计？\n\n<reference text>: Ann Oncol 12, 967-974 (2001).1668.Coronel, J., et al.A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于晚期宫颈癌患者的治疗方案，有研究在临床试验中采用了化疗联合表观遗传疗法，具体为使用氢氯噻唑和丙戊酸。这项研究设计为双盲、安慰剂对照、随机化的三期试验。该方案旨在评估这两种药物在化疗基础上的潜在益处，为晚期宫颈癌治疗提供新的思路。"
}